Discussion  by unknown
Narsule et al Evolving Technology/Basic Scienceendoscopic fundoplication compares favorably because
there were no deaths and only 1 report of pneumonia, al-
though there were 3 wrap disruptions in almost half as
many total patients as treated with laparoscopy in the
aforementioned randomized series. Laine and colleagues26
had also previously reported a prospective randomized
study comparing laparoscopic with open Nissen fundopli-
cation for patients with GERD and demonstrated no oper-
ative mortality and a mean hospital stay of 3.2 days for the
laparoscopic group and 6.4 days for the open group. Our
series is comparable, with no mortality and a mean hospital
stay of 1.3 days.
Our initial experience with endoscopic fundoplication is
currently limited to 46 patients. In addition, our follow-up is
of short duration.Moreover, although therewas a significant
reduction in the number of patients who were still taking
PPIs postoperatively, almost half of the treatment popula-
tion is still taking PPIs, either at a lower dose or at least
occasionally.
It is unlikely that endoscopic fundoplication will ever
completely replace laparoscopic fundoplication because
endoscopic fundoplication can only be used for patients
with small or no hiatal hernias. However, if results prove
to be durable, endoscopic fundoplication may become the
procedure of choice for those patients who are candidates
for this less invasive procedure. There may be other advan-
tages that may make this approach preferable for patients
with impaired esophageal motility.
In conclusion, we have demonstrated that endoscopic
fundoplication is feasible, can be performed with a low in-
cidence of complications, and is effective in a majority of
patients at short-term follow-up. Further study is needed
to define long-term outcomes and predictors of treatment
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Dr W. Randolph Chitwood, Jr (Greenville, NC). I think the
next step should be a randomized study between a laparoscopic
Nissen operation and this procedure. Do these patients have the
same postoperative characteristics as those having a laparoscopic
Nissen as far as failure to eructate?
DrNarsule. They have very similar characteristics. They some-
times have postoperative bloat that we have been able to control
with simethicone effectively thereafter.rdiovascular Surgery c Volume 143, Number 1 233




SDr Bryan Fitch Meyers (St. Louis, Mo). There are some end
points that are often talked about around antireflux surgery, both
before and after. One is a DeMeester score or 24-hour pH monitor-
ing. I did not see any data there or for manometry. Did you observe
any objective manometric change or objective reduction in the De-
Meester score after the implementation of this device?
Dr Narsule. In this study, we did not, because we did not delib-
erately have all of our patients undergo further studies. Simply put,
after they followed up with us, we assessed the efficacy of the en-
doscopic fundoplication on the basis of their symptomatology and
their response to the HRQL survey instrument. If there were issues
of dissatisfaction or persistent symptoms, we worked them up. But
aside from that, we did not perform any additional studies.
DrMeyers.Moving forward, I think that would be an important
thing to truly demonstrate the clinical effectiveness of this therapy.
Patients who undergo this treatment want to get better, and there is
going to be a certain measurable placebo effect. The self-reported
quality of life and the rate of change in the use of PPIs are pretty
soft end points for something that could have a potentially big uti-
lization and cost associated with it.
Dr G. Hossein Almassi (Milwaukee, Wis). Nice work. I have 2
questions. How easy is it to do a redo after a failed endoscopy?
Have you had any failures and did you do a redo endoscopic Nissen
again?
Dr Narsule. The redo is very similar to the initial operation. We
were fortunate to have information as to where the wrap had dis-
rupted and, endoscopically, we were able to see the points of laxity
that occurred after the first procedure.Wewere able to target where
exactly to place the polypropylene H-fasteners. It was far easier
than we had anticipated preoperatively.234 The Journal of Thoracic and Cardiovascular SurgDr Almassi. I know gastroenterologists are not cardiologists,
but what do you think will happen in the future? Are gastroenter-
ologists going to be doing this procedure?
Dr Narsule. I do not think that the future of this procedure
would be in the hands of the gastroenterologists alone, because I
think that there is an increased complexity to performing a fundo-
plasty. There have been other endoscopic approaches to the treat-
ment of GERD, and they have not persisted. Although they tried to
decrease the compliance of the LES, perhaps because a fundoplasty
had not fully been considered with those interventions, they were
not durable. Adding a fundoplasty as part of the endoscopic ap-
proach requires the special perspective that the surgeon has in per-
forming this procedure. Although it is an endoscopic procedure, it
is a procedure that is performed along the same principles. I think
that the results will be better and more durable in the hands of
surgeons.
Dr Toni Lerut (Leuven, Belgium). I have a follow-up question
on that. In Europe, the future is already in the hands of the gastro-
enterologists, because they are doing most of these procedures. It
is so in our institution, but they do it together with us, and we do
have a similar experience. What it shows on 24-hour pH monitor-
ing is that this procedure decreases the volume of reflux, but it does
not abolish it as efficiently as after a laparoscopic Nissen proce-
dure. Would you advocate this type of procedure, for instance, in
patients with Barrett’s metaplasia?
Dr Narsule. For patients who do have Barrett’s metaplasia, de-
pending on whether it is dysplastic or not, I think that this proce-
dure would still be very applicable. In fact, 5 of our patients had
Barrett’s esophagus, had an intervention for the metaplasia, and
then subsequently underwent this procedure.ery c January 2012
